A fourth Phase 3 clinical trial in the US to evaluate an investigational Covid-19 vaccine was underway and has started enrolling...
Read moreDetailsLeading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis...
Read moreDetailsScientists have identified a new drug that could prevent or mitigate the consequences derived from infection by SARS-CoV-2, the virus...
Read moreDetailsUnion Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by...
Read moreDetailsThe Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Limited, a global pharmaceutical company headquartered in India, have agreed...
Read moreDetailsThe coronavirus vaccine might be ready by the first quarter of 2021, Union Health and Family Welfare Minister Harsh Vardhan...
Read moreDetailsThe Ministry of Health and Family Welfare stressed on ayurvedic intervention to manage post-COVID conditions in its latest guidelines issued...
Read moreDetailsIn a major study, researchers have shown that convalescent plasma appears to be a safe and possibly effective treatment for...
Read moreDetailsThe Supreme Court Monday asked states to file a detailed affidavit within four weeks on a plea seeking directions to...
Read moreDetailsFor the second consecutive day, India has clocked recovery of more than 70,000 Covid-19 patients in a single day, the...
Read moreDetailsEnewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.
ssss
© 2025 Designed & Developed with ❤️ by Provibe Media LLP
© 2025 Designed & Developed with ❤️ by Provibe Media LLP